Originally published by FinSMEs on August 10, 2022
Maximus, a Los Angels, CA-based consumer telemedicine company for men’s health and hormone optimization, raised $15M in funding.
The round was led by Keith Rabois, with participation from 8VC, Abstract Ventures, 10X Capital, Unshackled Ventures, OneVC, Gaingels, Correlation Ventures, Chamaeleon VC, Rational Ventures, WhatIf Ventures, Shrug Capital, Electric Ant, Dave Asprey, Ryan Holiday, Brain Lee, Jeff Weiser, Brian Nogard, Kyle Samani, Matteo Franceschetti, and Geoffrey Wu.
The company intends to use the funds to expand its reach, grow brand awareness, and invest in product development.
Led by CEO Dr. Cam Sepah, Maximus is a consumer telemedicine company that offers performance enhancement space by democratizing doctor-prescribed protocols developed by experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. The Lover Protocol is a synergistic combination of prescription medications that enhances blood flow and libido to improve both sexual performance and enjoyment. The company also helps its members optimize their nutrition, exercise, sleep, and focus through its live weekly health coaching sessions with Dr. Sepah and its online Discord community where new and fellow members support and learn from each other.
Currently, Maximus is available in 15 states across the U.S.